Track topics on Twitter Track topics that are important to you
The Association of the British Pharmaceutical Industry (ABPI) has suspended Astellas UK’s membership for a further 12 months from Jun. 24 because of several serious breaches of its Code of Practice. The association said recent cases at both Astellas UK and Astellas Pharma Europe have shown “wholly inadequate oversight and control and a lamentable lack of concern for patient safety.”
Original Article: ABPI Extends Suspension of Astellas UKNEXT ARTICLE
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...